
Articles
-
2 months ago |
securities.io | Joshua Stoner
Fractional real estate investing has the potential to transform how retail and institutional investors alike engage with the property market. Where traditional real estate investing often requires substantial capital and involves significant management responsibilities, fractional ownership provides investors with the ability to purchase shares of professionally managed properties.
-
Dec 4, 2024 |
securities.io | Joshua Stoner
After ~15 years, Bitcoin has become one of the most improbable and inspiring success stories in the modern age. It is a global phenomenon that has captivated believers and naysayers alike through wild market cycles, stories of forward-thinking investors going from rags to riches, and sometimes controversial events – all spawning from an enigmatic creator and his/her/their whitepaper.
-
Nov 15, 2024 |
securities.io | Joshua Stoner
Securities.io is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Trading involves risk which may result in the loss of capital. If you haven't heard already, President-elect Donald J. Trump has pledged to establish a strategic reserve of Bitcoin (BTC) by the U.S. government. While this has helped further fuel the asset's current bull run, many still see this as unneeded or are wary of doing so.
-
Oct 30, 2024 |
securities.io | Joshua Stoner
In less than a decade, Scale AI has managed to become a leading force in data labeling and model training for artificial intelligence. It has done so by revolutionizing the way businesses approach machine learning. Its mission is simple – provide companies with the ability to train and build AI systems by harnessing high-quality data.
-
Aug 2, 2024 |
securities.io | Joshua Stoner
In a recent clinical trial, researchers have come to various intriguing conclusions regarding the medicinal properties of Cannabis. The study, titled ‘Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial,‘ was first published on Nature.com and detailed the researcher's findings on one cannabinoid in particular – Cannabigerol (CBG).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 356
- Tweets
- 34
- DMs Open
- Yes

RT @jespow: The King👑 in the House. 🙇♂️

RT @securitiesio: Sam Bankman-Fried (SBF) Criminal Indictment Unsealed & What it Means https://t.co/9arMGgUl2m

RT @IUOEnsparamedic: Right now at the QEII. Paramedic crews today responding from hours upon hours away; the company using social media to…